Advertisement

Topics

Persistent sex disparities in implantable cardioverter-defibrillator therapy.

08:00 EDT 30th June 2018 | BioPortfolio

Summary of "Persistent sex disparities in implantable cardioverter-defibrillator therapy."

Clinical guidelines recommend cardioverter defibrillator implantation for patients with heart failure and reduced ejection fraction. Despite this, women and minorities have been less likely to receive implantable cardioverter-defibrillator (ICD) therapy than white men. We examined race and sex differences in ICD implantation in a recent cohort.

Affiliation

Journal Details

This article was published in the following journal.

Name: Pacing and clinical electrophysiology : PACE
ISSN: 1540-8159
Pages:

Links

DeepDyve research library

PubMed Articles [10782 Associated PubMed Articles listed on BioPortfolio]

Deactivation of Implantable Cardioverter-Defibrillators in Heart Failure: A Systematic Review.

Implantable cardioverter-defibrillator aids in the prevention of cardiac arrest by delivering an electrical shock in the presence of life-threatening ventricular arrhythmias. Although implantable card...

Conscious sedation during subcutaneous implantable cardioverter-defibrillator implantation using the intermuscular technique.

The subcutaneous implantable cardioverter-defibrillator (S-ICD) system is an established therapy for the prevention of sudden cardiac death (SCD) and an alternative to a transvenous implantable cardio...

Patient with the intervention of an implantable cardioverter-defibrillator in a hospital emergency department.

Introduction: Implantable cardioverter-defibrillators (ICD) improve prognosis in patients with malignant ventricular arrhythmias. Patients with ICD represent a significant proportion of all Emergency ...

Trends in implantable cardioverter defibrillator and cardiac resynchronisation therapy lead parameters for patients with arrhythmogenic and dilated cardiomyopathies.

Implantable cardioverter-defibrillator (ICD) lead parameters may deteriorate due to right ventricular (RV) disease such as arrhythmogenic right ventricular cardiomyopathy (ARVC), with implications for...

Use and Outcomes of Subcutaneous Implantable Cardioverter Defibrillator (ICD) After Trans-venous ICD Extraction: an Analysis of Current Clinical Practice and a Comparison with Trans-venous ICD Reimplantation.

The subcutaneous implantable cardioverter-defibrillator (S-ICD) does not require the insertion of any leads into the cardiovascular system.

Clinical Trials [3879 Associated Clinical Trials listed on BioPortfolio]

Multicenter Automatic Defibrillator Implantation Trial With Subcutaneous Implantable Cardioverter Defibrillator

The MADIT S-ICD trial is designed to evaluate if subjects with a prior myocardial infarction, diabetes mellitus and a relatively preserved ejection fraction of 36-50% will have a survival ...

The Gulf Implantable Cardioverter-Defibrillator Registry

This is a prospective observational multi-center multi-national study of the characteristics and outcomes of patients receiving implantable cardioverter-defibrillators (ICD) in the Arab Gu...

ConsultaTM CRT-D Clinical Evaluation Study

The purpose of the Consulta clinical study is to evaluate the overall system safety and clinical performance of the Consulta Implantable Cardioverter Defibrillator with Cardiac Resynchroni...

Psychosomatic Effects of Implantable Cardioverter Defibrillator With Home Monitoring Function (QUANTUM)

Quality of life (QOL) and psychological well-being of patients with implantable cardioverter-defibrillators (ICDs) are significantly influenced by the experience of shock therapies. A clos...

SecuraTM ICD Clinical Evaluation Study

The purpose of the Secura clinical study is to evaluate the overall system safety and clinical performance of the Secura DR Implantable Cardioverter Defibrillator (ICD)

Medical and Biotech [MESH] Definitions

Types of artificial pacemakers with implantable leads to be placed at multiple intracardial sites. They are used to treat various cardiac conduction disturbances which interfere with the timing of contraction of the ventricles. They may or may not include defibrillating electrodes (IMPLANTABLE DEFIBRILLATORS) as well.

Implantable devices which continuously monitor the electrical activity of the heart and automatically detect and terminate ventricular tachycardia (TACHYCARDIA, VENTRICULAR) and VENTRICULAR FIBRILLATION. They consist of an impulse generator, batteries, and electrodes.

Preliminary cancer therapy (chemotherapy, radiation therapy, hormone/endocrine therapy, immunotherapy, hyperthermia, etc.) that precedes a necessary second modality of treatment.

Differences in access to or availability of facilities and services

Variation in rates of disease occurrence and disabilities between socioeconomic and /or geographically defined population groups.

Advertisement
Quick Search
Advertisement
Advertisement

 


DeepDyve research library

Relevant Topic

Women's Health
Women's Health - key topics include breast cancer, pregnancy, menopause, stroke Follow and track Women's Health News on BioPortfolio: Women's Health News RSS Women'...


Searches Linking to this Article